Fulcrum Therapeutics, Inc. — SC 13G/A Filings
34 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Fulcrum Therapeutics, Inc. (FULC), sorted by most recent first. Each row links to the full filing on EdgarLookup. Fulcrum Therapeutics, Inc. has filed 34 SC 13G/A documents with the SEC since 2016. To view all SEC filings by Fulcrum Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | — | 0000919574-24-006744 | Nov 14, 2024 | — |
| SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-24-006487 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000932471-24-001033 | Nov 12, 2024 | — |
| SC 13G/A | — | 0000932471-24-000432 | Nov 4, 2024 | — |
| SC 13G/A | — | 0000315066-24-002025 | Oct 7, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-100319 | Sep 16, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-092442 | Aug 23, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023996 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-036266 | Feb 14, 2024 | — |
| SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-24-001576 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000919574-24-000953 | Feb 13, 2024 | — |
| SC 13G/A | — | 0000315066-24-001144 | Feb 9, 2024 | — |
| SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-24-001172 | Feb 7, 2024 | — |
| SC 13G/A | — | 0001306550-23-009506 | Jul 7, 2023 | — |
| SC 13G/A | SCHEDULE 13G/A, AMENDMENT #1 | 0000899140-23-000389 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-039067 | Feb 14, 2023 | — |
| SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-23-001712 | Feb 14, 2023 | — |
| SC 13G/A | — | 0000919574-23-000956 | Feb 13, 2023 | — |
| SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-23-001349 | Feb 9, 2023 | — |
| SC 13G/A | — | 0000315066-23-001651 | Feb 9, 2023 | — |
| SC 13G/A | — | 0001306550-23-006387 | Feb 1, 2023 | — |
| SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 0001085146-23-000296 | Jan 23, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-001871 | Jan 6, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-22-042150 | Feb 14, 2022 | — |
| SC 13G/A | FULCRUM THERAPEUTICS, INC. | 0000902664-22-001590 | Feb 14, 2022 | — |
| SC 13G/A | — | 0000919574-22-000896 | Feb 11, 2022 | — |
| SC 13G/A | — | 0000315066-22-001008 | Feb 9, 2022 | — |
| SC 13G/A | — | 0000315066-21-001729 | Sep 10, 2021 | — |
| SC 13G/A | SCHEDULE 13G (AMENDMENT #1) | 0000899140-21-000296 | Feb 16, 2021 | — |
| SC 13G/A | SCHEDULE 13G/A | 0001104659-21-023348 | Feb 16, 2021 | — |
| SC 13G/A | — | 0001493152-21-003557 | Feb 12, 2021 | — |
| SC 13G/A | — | 0000919574-21-000829 | Feb 11, 2021 | — |
| SC 13G/A | — | 0000315066-21-001009 | Feb 8, 2021 | — |
| SC 13G/A | SC 13G/A | 0001104659-20-020454 | Feb 14, 2020 | — |